Property developers are circling prime sites being rezoned for high-density development to tackle the housing shortage on Sydney’s north shore. However, the demand for apartments has been superseded by a different type of tenant on one key site.
Laboratory space for hundreds of scientists working for biotechs and other life science start-ups – which hope to become the next Cochlear or CSL – is in short supply.
Loading...
Michael Smith is the health editor for The Australian Financial Review. He is based in Sydney. Connect with Michael on Twitter. Email Michael at michael.smith@afr.com